Ultraviolet A1-induced downregulation of human β-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma

British Journal of Dermatology

Volumn 155, Issue 3, 2006, Pages 600-607

  Kreuter, A ^a   Hyun, J ^a   Skrygan, M ^a   Sommer, A ^a   Bastian, A ^a   Altmeyer, P ^a   Gambichler, T ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Human beta defensins; Interleukin 6; Interleukin 8; Localized scleroderma; Ultraviolet A1 irradiation

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; COLLAGEN; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; INFLAMMATION; LOCALIZED SCLERODERMA; MALE; PATHOGENESIS; PHOTOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET A1 RADIATION;

ADULT; BETA-DEFENSINS; DOWN-REGULATION; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; SKIN; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 33747073123     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07391.x     Document Type: Article

References (22)

1. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995; 70:1068-76.
2. Ihn H, Sato S, Fujimoto M et al. Demonstration of interleukin 8 in serum samples of patients with localized scleroderma. Arch Dermatol 1994; 130:1327-8.
3. Ihn H, Sato S, Fujimoto M et al. Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res 1995; 287:193-7.
4. Harder J, Bartels J, Christophers E, Schröder JM. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276:5707-13.
5. Schröder JM. Epithelial antimicrobial peptides: innate local host response elements. Cell Mol Life Sci 1999; 56:32-46.
6. Valore EV, Park CH, Quayle AJ et al. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101:1633-42.
7. Harder J, Bartels J, Christophers E, Schröder JM. A peptide antibiotic from human skin. Nature 1997; 387:861.
8. Sha WC. Regulation of immune response by NFκB/Rel transcription factor. J Exp Med 1998; 187:143-6. Erratum in: J Exp Med 1998;187:661.
9. Sorensen OE, Cowland JB, Theilgaard-Monch K et al. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003; 170:5583-9.
10. Varga J. Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum 2002; 46:1703-13.
11. Wlaschek M, Heinen G, Postwig A et al. UVA-induced autocrine stimulation of fibroblast-derived-collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol 1994; 59:550-6.
12. Seo SJ, Ahn SW, Hong CK, Ro BI. Expression of β-defensins in human keratinocyte cell lines. J Dermatol Sci 2001; 27:183-91.
13. Seyger MMB, van den Hoogen FHJ, de Boo T, de Jong EMGJ. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol 1998; 39:220-5.
14. Kandono T, Kikuchi K, Ihn H et al. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts. J Rheumatol 1998; 25:296-301.
15. Duncan MR, Berman B. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 1991; 97:686-92.
16. Hasegawa M, Sato S, Fujimoto M et al. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble sgp130 in patients with systemic sclerosis. J Rheumatol 1998; 25:308-13.
17. Nagaoka T, Sato S, Hasegawa M et al. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma. J Rheumatol 2000; 27:1917-21.
18. Murphy CJ, Foster BA, Mannis MJ et al. Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 1993; 155:408-13.
19. Liu L, Wang L, Jia HP et al. Structure and mapping of the human β-defensin HBD-2 gene and its expression at sites of inflammation. Gene 1998; 222:237-44.
20. Butmarc J, Yufit T, Carson P, Falanga V. Human β-defensin-2 expression is increased in chronic wounds. Wound Repair Regen 2004; 12:439-43.
21. Quan T, He T, Kang S et al. Ultraviolet irradiation alters transforming growth factor β/smad pathway in human skin in vivo. J Invest Dermatol 2002; 119:499-506.
22. Erdag G, Morgan JR. Interleukin-1α and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann Surg 2002; 235:113-24.